1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Asia-Pacific Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality ; End User, and Country

Asia-Pacific Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality ; End User, and Country

  • March 2020
  • 166 pages
  • ID: 5887348
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The Asia Pacific colorectal cancer market was valued at US$ 3,313.9 million in 2019 and is projected to reach US$ 4,900.6 million by 2027; it is expected to grow at a CAGR of 4.5% from 2020 to 2027.

The growth of the Asia Pacific colorectal cancer market is primarily ascribed to the increasing prevalence of colorectal cancer, rising number of new product launches, and benefits of generic drugs.On the other hand, pricing pressure on drug manufacturers is restraining the growth of the market.

In contrast, growth of emerging markets in developing countries is expected to have a fuel the Asia Pacific colorectal cancer market in the coming years.
Colorectal cancer is one of the commonly found and lethal cancers caused through a combined influence of genetic and environmental factors, and it affects colon, bowel, and rectum.It is the second-leading cause of death in women and third in men.

Colorectal cancer may be benign, malignant, or non-cancerous.The symptoms shown by the people suffering from colon cancer include changes in bowel habits, including diarrhea or constipation, and blood in stools that makes it appear black.

Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.
Cancer has been a leading cause of deaths in Japan since several decades.The Japanese government has been formulating and laying down multiple initiatives and programs to enhance the quality of cancer treatment and increase awareness regarding cancer in the country.

In December 2015, it formulated the “Acceleration plan for cancer control.” In November 2016, a bill was submitted to revise a part of the Cancer Control Act, which was enacted and implemented in December. In December 2016, the Genome Medical Forum 2016 was organized to provide an opportunity to reconstruct the cancer medical system.
The cases of cancer have significantly increased in Japan in the recent years.As per the data obtained by the WHO, ~883,395 new cancer cases were detected in 2018, with ~409,399 due to the same in that years.

Among men, the prevalence of colorectum, lung, stomach, prostate, and bladder cancers was significantly high.On the other hand, among women, breast, colorectum, and lung cancers were detected in large numbers.

In spite of the available options, participation is as low as 35% of the target population for both forms of cancer. The increasing prevalence of cancer, coupled with available options for screening, is expected to fuel the growth of the colorectal cancer market in Asia Pacific at a significant pace during the forecast period.

In 2019, the diagnosis segment accounted for the largest share of the Asia Pacific colorectal cancer market based on type.The growth of the market for this segment is attributed to rising number of colorectal cancer screening programs and initiatives across the world.

The diagnosis segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological developments that are enabling the early detection of this cancer through various screening methods.
In 2019, the hospitals segment held the most significant share of the colorectal cancer market, by the end user.This segment is also anticipated to hold a considerable portion of the market by 2027 owing to the need for hospitals as primary healthcare centers for the people.

The segment is also anticipated to register significant CAGR in the market during the forecast period.
A few of the prime secondary sources studied for preparing the colorectal cancer market report are World Health Organization (WHO), Food and Drug Administration (FDA), Canadian Cancer Society, Centers for Disease Control and Prevention (CDC), and American Cancer Society.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Gallbladder Cancer - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 695 pages

Gallbladder Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer – Pipeline Review, H1 2020, provides an overview of the Gallbladde ...


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on